Should You Buy AbbVie Stock Before April 29?

April 07, 2026 — 07:05 am EDT Written byDavid JagielskiforThe Motley Fool-> AbbVie's growth rate has been impressive given the headwinds it has faced. This year, it's forecasting a significant increase in its earnings. AbbVie(NYSE: ABBV)is a leading drugmaker that investors have come to rely on for steady and consistent results over the years. Along the way, it has also paid and increased its dividend on a regular basis. It's been one of the better healthcare stocks to own, and it has nearly doubled in value in just five years. This year, it's been off to a tough start, declining by around 10%